Expression and function of peroxisome proliferator-activated receptors in human melanocytes

被引:53
|
作者
Kang, HY [1 ]
Chung, E
Lee, M
Cho, Y
Kang, WH
机构
[1] Ajou Univ, Dept Dermatol, Sch Med, Suwon 442721, South Korea
[2] Ajou Univ, Dept Microbiol, Sch Med, Suwon 442721, South Korea
关键词
melanocyte; melanogenesis; peroxisome proliferator-activated receptors; proliferation;
D O I
10.1111/j.1365-2133.2004.05844.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Peroxisome proliferator-activated receptors (PPARs) belong to the superfamily of nuclear receptors that heterodimerize with the retinoic X receptor. Agonists of PPAR have been known to play an important role in cellular responses including proliferation and differentiation. The expression and function of PPARs have not been investigated in human melanocytes, although they have been widely demonstrated in keratinocytes of the skin. Objectives To investigate the expression of PPARs in human melanocytes and the effects of PPAR activators on melanocyte growth and melanogenesis. Methods We used immunocytochemistry and Western blot analysis to determine whether PPARs are expressed in melanocytes. To investigate further expression of PPAR subtypes, reverse transcriptase-polymerase chain reaction analysis was performed using PPAR subtype-specific oligonucleotides. The cell proliferation was measured using the Coulter counter. The effects on pigmentation were investigated with measurement of melanin contents, tyrosinase activity and its expression. Results The mRNA of all three PPAR subtypes, PPAR-alpha, PPAR-beta/delta and PPAR-gamma, were expressed in melanocytes. Activators for PPAR-alpha (WY-14643) and PPAR-gamma (ciglitazone) inhibited proliferation of melanocytes in a dose-dependent manner, whereas bezafibrate, a preferential activator for PPAR-beta/delta, had no effect. This growth inhibition was accompanied by the morphological change of the melanocytes to an activated form with an increased number of dendrites and enlarged cell area compared with the control. The WY-14643 and ciglitazone also appeared to stimulate the melanin synthesis of melanocytes. This increase in pigmentation was due to stimulation of the tyrosinase activity without an increase in the expression of tyrosinase. Conclusions PPARs are expressed in human melanocytes and PPAR-alpha and PPAR-gamma activators inhibit melanocyte growth and stimulate melanogenesis.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 50 条
  • [1] Variable expression of peroxisome proliferator-activated receptors in human atherosclerosis
    Sueyoshi, S
    Yamada, T
    Esumi, M
    Kusumi, Y
    Niihashi, M
    Tsuru, K
    Imai, S
    Nemoto, N
    Sakurai, I
    Mitsumata, M
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 217 - 217
  • [2] Peroxisome proliferator-activated receptors: Structures and function
    Tugwood, JD
    Aldridge, TC
    Lambe, KG
    Macdonald, N
    Woodyatt, NJ
    [J]. PEROXISOMES: BIOLOGY AND ROLE IN TOXICOLOGY AND DISEASE, 1996, 804 : 252 - 265
  • [3] Peroxisome proliferator-activated receptors in human atherosclerosis
    Lestavel, S
    Chinetti, G
    Bocher, V
    Fruchart, JC
    Clavey, V
    Staels, B
    [J]. M S-MEDECINE SCIENCES, 2001, 17 (05): : 637 - 642
  • [4] The expression of peroxisome proliferator-activated receptors (PPARs) in the podocytes
    Lee, CH
    Kuo, MC
    Guh, JY
    Chen, HC
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V210 - V210
  • [5] Proliferating peroxisome proliferator-activated receptors
    不详
    [J]. DIABETES OBESITY & METABOLISM, 2000, 2 (05): : 332 - 333
  • [6] Peroxisome proliferator-activated receptors and inflammation
    Moraes, Leonardo A.
    Piqueras, Laura
    Bishop-Bailey, David
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 110 (03) : 371 - 385
  • [7] Peroxisome proliferator-activated receptors for hypertension
    Usuda, Daisuke
    Kanda, Tsugiyasu
    [J]. WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (08): : 744 - 754
  • [8] Peroxisome proliferator-activated receptors and their functions
    Jiao, HL
    Ye, P
    Zhao, BL
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (04) : 478 - 481
  • [9] Peroxisome proliferator-activated receptors.
    Ziouzenkova O.
    Perrey S.
    Marx N.
    Bacqueville D.
    Plutzky J.
    [J]. Current Atherosclerosis Reports, 2002, 4 (1) : 59 - 64
  • [10] Signalling by peroxisome proliferator-activated receptors
    Wahli, W
    Krey, G
    Devchand, P
    Keller, H
    Ijpenberg, A
    Jeannin, E
    Braissant, O
    Desvergne, A
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U79 - U79